ISX:DGNS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ISX:DGNS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PT Diagnos Laboratorium Utama Tbk's enterprise value is Rp265,000.00 Mil. PT Diagnos Laboratorium Utama Tbk does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue at this moment.
The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue or its related term are showing as below:
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-12-14), PT Diagnos Laboratorium Utama Tbk's stock price is Rp212.00. PT Diagnos Laboratorium Utama Tbk does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PT Diagnos Laboratorium Utama Tbk's PS Ratio at this moment.
The historical data trend for PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diagnos Laboratorium Utama Tbk Annual Data | |
Trend | |
EV-to-Revenue |
PT Diagnos Laboratorium Utama Tbk Semi-Annual Data |
EV-to-Revenue |
For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 265000.000 | / | ||
= |
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
PT Diagnos Laboratorium Utama Tbk's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 212.00 | / | ||
= |
Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
From GuruFocus
By Business Wire Business Wire • 11-12-2021
By Business Wire Business Wire • 12-07-2021
By Business Wire Business Wire • 11-12-2021
By Business Wire Business Wire • 12-07-2021
By Business Wire Business Wire • 11-29-2021
By Business Wire Business Wire • 12-06-2021
By Business Wire Business Wire • 06-04-2021
By Business Wire Business Wire • 12-01-2021
By Business Wire Business Wire • 07-23-2021
By Business Wire Business Wire • 11-18-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.